EUVIMEDEUVIMED entdecken
Crossref

Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes

Denise M Kay, Hossein Sadeghi, Catherine Kier, Maria Berdella, Joan K DeCelie-Germana, Zafer N Soultan, Danielle M Goetz, Michele Caggana, Christopher N Fortner, Robert Giusti, Robert Kaslovsky, Colleen Stevens und 4 weitere

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.27023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Denise M Kay und 15 weiteren Autor:innen. Beteiligte Einrichtung: Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, Genetic Counseling, Neonatal Screening. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

New York State (NYS) utilizes a three‐tiered cystic fibrosis newborn screening (CFNBS) algorithm that includes cystic fibrosis transmembrane conductance regulator ( CFTR ) gene sequencing. Infants with >1 CFTR variant of potential clinical relevance, including variants of uncertain significance or varying clinical consequence are referred for diagnostic evaluation at NYS cystic fibrosis (CF) Specialty Care Centers (SCCs).

Aims

As part of ongoing quality improvement efforts, demographic, screening, diagnostic, and clinical data were evaluated for 289 CFNBS‐positive infants identified in NYS between December 2017 and November 2020 who did not meet diagnostic criteria for CF and were classified as either: CFTR ‐related metabolic syndrome/CF screen positive, inconclusive diagnosis (CRMS/CFSPID) or CF carriers.

Results

Overall, 194/289 (67.1%) had CFTR phasing to confirm whether the infant's CFTR variants were in cis or in trans . Eighteen complex alleles were identified in cis ; known haplotypes (p.R117H+5T, p.F508del+p.L467F, and p.R74W+p.D1270N) were the most common identified. Thirty‐two infants (16.5%) with all variants in cis were reclassified as CF carriers rather than CRMS/CFSPID. Among 263 infants evaluated at an NYS SCC, 70.3% were reported as having received genetic counseling about their results by any provider, with 96/263 (36.5%) counseled by a certified genetic counselor.

Conclusion

Given the particularly complex genetic interpretation of results generated by CFNBS algorithms including sequencing analysis, additional efforts are needed to ensure families of infants with a positive CFNBS result have CFTR phasing when needed to distinguish carriers from infants with CRMS/CFSPID, and access to genetic counseling to address implications of CFNBS results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisGenetic CounselingNeonatal ScreeningParentsGenotypeHumansNew YorkInfant, NewbornMaleFemalePhenotypeHealth Services AccessibilityInfant

Stichwörter der Autor:innen

CF IRT‐DNA‐SEQ algorithmCF screen positiveCF screen positive, inconclusive diagnosisCFTR phasing analysisCFTR‐related metabolic syndromecystic fibrosis newborn screeninggenetic counseling

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorCFTR protein, human

Autor:innen und Institutionen

  • Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, USA.
  • Columbia University Irving Medical Center, New York City, New York, USA.
  • Department of Pediatrics, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA.
  • Lenox Hill Hospital, Northwell Health System, New York City, New York, USA.
  • Cohen Children's Medical Center, Northwell Health System, New Hyde Park, New York, USA.
  • Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Upstate Medical University, Syracuse, New York, USA.

Förderung

  • None

Zitieren

APA

Kay, D. M., Sadeghi, H., Kier, C., Berdella, M., DeCelie-Germana, J. K., Soultan, Z. N., Goetz, D. M., Caggana, M., Fortner, C. N., Giusti, R., Kaslovsky, R., Stevens, C., Voter, K., Welter, J. J., New York State Cystic Fibrosis Newborn Screening Consortium, & Langfelder-Schwind, E. (2024). Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27023

Vancouver

Kay DM, Sadeghi H, Kier C, Berdella M, DeCelie-Germana JK, Soultan ZN, et al. Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27023

BibTeX
@article{Kay2024,
  author = {Kay, Denise M and Sadeghi, Hossein and Kier, Catherine and Berdella, Maria and DeCelie-Germana, Joan K and Soultan, Zafer N and Goetz, Danielle M and Caggana, Michele and Fortner, Christopher N and Giusti, Robert and Kaslovsky, Robert and Stevens, Colleen and Voter, Karen and Welter, John J and New York State Cystic Fibrosis Newborn Screening Consortium, New York State Cystic Fibrosis Newborn Screening Consortium and Langfelder-Schwind, Elinor},
  title = {Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.27023}
}
Kostenlos starten →